ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Sernova Biotherapeutics Inc (PK)

Sernova Biotherapeutics Inc (PK) (SEOVF)

0,11
0,00
(0,00%)
Geschlossen 12 Juni 10:00PM

Sernova Biotherapeutics Inc (PK) (SEOVF) Insidergeschäfte

-
Filtern nach:
Datum Name des Inhabers Gehandelte Aktien Wertspanne ($) Transaktionstyp Preisspanne ($) Aktien am Meldungsende % Veränderung
2026-05-22Ms. Tanya N. LewisIndependent Director & Observer426,48k0,00Derivative Acquisition Under Employee Benefit Plan-1,56M37,63%
2026-05-22Mr. David PatersonIndependent Director454,23k0,00Derivative Acquisition Under Employee Benefit Plan-1,73M35,53%
2026-05-22Dr. Stephen SanghaIndependent Director260,00k0,00Derivative Acquisition Under Employee Benefit Plan-2,54M11,40%
2026-05-22Dr. Bernd MuehlenwegIndependent Director433,42k0,00Derivative Acquisition Under Employee Benefit Plan-1,74M33,30%
2026-05-22Mr. John L. BrooksIndependent Chairman588,91k0,00Derivative Acquisition Under Employee Benefit Plan-1,73M51,45%
2026-04-16Dr. Stephen SanghaIndependent Director26,67M2,92MKauf0,1149,70M115,76%
2026-04-14Dr. Stephen SanghaIndependent Director10,00M1,09MKauf0,1123,04M76,70%
2026-04-14Mr. Jonathan M. N. RigbyPresident, CEO & Director229,88k31,74kKauf0,14229,88k-
2026-04-14Mr. James T. ParsonsCFO229,88k31,74kKauf0,14614,61k59,75%
2026-03-03Mr. James T. ParsonsCFO-100,00k0,00Other Derivative Disposition-0,00-100,00%
2026-03-03Dr. Stephen SanghaIndependent Director-880,00k0,00Other Derivative Disposition-16,00M-5,21%
2026-02-24Mr. John L. BrooksIndependent Chairman1,14M0,00Derivative Acquisition Under Employee Benefit Plan-1,14M-
2026-02-24Mr. James T. ParsonsCFO2,25M0,00Derivative Acquisition Under Employee Benefit Plan-7,32M44,38%
2026-02-24Mr. Jonathan M. N. RigbyPresident, CEO & Director3,80M0,00Derivative Acquisition Under Employee Benefit Plan-19,98M23,48%
2026-02-24Dr. Bernd MuehlenwegIndependent Director337,47k0,00Derivative Acquisition Under Employee Benefit Plan-1,30M35,00%
2026-02-24Dr. Pericles CaliasChief Development Officer and Head of R&D600,00k0,00Derivative Acquisition Under Employee Benefit Plan-1,60M60,00%
2026-02-24Dr. Stephen SanghaIndependent Director880,00k0,00Derivative Acquisition Under Employee Benefit Plan-2,28M62,85%
2026-02-24Mr. David PatersonIndependent Director377,97k0,00Derivative Acquisition Under Employee Benefit Plan-1,28M41,97%
2026-02-24Ms. Tanya N. LewisIndependent Director & Observer323,97k0,00Derivative Acquisition Under Employee Benefit Plan-1,13M40,03%
2026-02-24Dr. Stephen SanghaIndependent Director269,98k0,00Derivative Acquisition Under Employee Benefit Plan-1,40M23,89%
2025-08-14Ms. Tanya N. LewisIndependent Director & Observer389,32k0,00Derivative Acquisition Under Employee Benefit Plan-809,32k92,70%
2025-08-14Dr. Bernd MuehlenwegIndependent Director404,19k0,00Derivative Acquisition Under Employee Benefit Plan-964,19k72,18%
2025-08-14Dr. Stephen SanghaIndependent Director420,26k0,00Derivative Acquisition Under Employee Benefit Plan-1,13M59,19%
2025-08-14Mr. David PatersonIndependent Director410,53k0,00Derivative Acquisition Under Employee Benefit Plan-900,53k83,78%
2025-08-01Mr. Jeffrey A. BachaInsider-5,00k724,68Verkauf0,14325,00k-1,52%